Abstract |
Neutrophil is a key element in inflammation and stress disease, which are associated with poor clinical outcomes in various cardiac diseases. However, the clinical availability of neutrophil in patients with ST-elevation myocardial infarction ( STEMI) and chronic renal dysfunction has not been known. Accordingly, we designed this retrospective cohort study to evaluate the differences of major adverse cardiovascular events incidence between renal dysfunctional STEMI patients with normal and high neutrophil levels. The primary end point was all-cause mortality. We analyzed 377 consecutive STEMI patients with chronic renal dysfunction. The results showed that during 12-48 months follow-up, death from any-cause occurred in 1.4% patients (4 of 290) in normal-level neutrophil group, as compared with 3.4% in high-level neutrophil group (3 of 87) (hazard ratio, 2.174 95% confidence interval, 1.024-10.248; P = 0.025). Kaplan-Meier survival analysis showed that there were significant differences between the two groups with respect to the risk of death (P=0.018), and heart failure (P=0.037).
|
Authors | Yuhan Cao, Cong Fu, Xin Wang, Chaojun Yu |
Journal | Open life sciences
(Open Life Sci)
Vol. 14
Pg. 659-665
(Jan 2019)
ISSN: 2391-5412 [Electronic] Poland |
PMID | 33817205
(Publication Type: Journal Article)
|
Copyright | © 2019 Yuhan Cao et al. published by De Gruyter. |